A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy
Authors:
- Gerd RippinGRGerd Rippin
- Peter SchenkPSPeter Schenk
- George FindlayGFGeorge Findlay
- Wilhelm WurstWWWilhelm Wurst
- Dietrich HäfnerDHDietrich Häfner
- James F. LewisJLJames F. Lewis
- Werner SeegerWSWerner Seeger
- Andreas GüntherAGAndreas Günther
- Roger G. SpraggRSRoger G. Spragg
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysisCritical Care, 2006
- Time to change diagnostic criteria of ARDS: toward the disease entity-based subgroupingPulmonary Pharmacology & Therapeutics, 2004
- Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2004
- Pharmacologic Treatments for Acute Respiratory Distress Syndrome and Acute Lung InjuryTreatments in Respiratory Medicine, 2004
- Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluationCritical Care Medicine, 2000
- Futility of randomized, controlled ARDS trials-A new approach is neededCritical Care Medicine, 1999
- Acute Respiratory Distress Syndrome Caused by Pulmonary and Extrapulmonary Disease: Different Syndromes?American Journal of Respiratory and Critical Care Medicine, 1998
- Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress SyndromeNew England Journal of Medicine, 1996
- Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordinationIntensive Care Medicine, 1994
- APACHE IICritical Care Medicine, 1985